Rasio Therapeutics, a drug development spin-off SilcsBio, LLC, is a U.S. based therapeutics company harnessing the full power of next generation computer aided drug design to bring novel medicines to the clinic.
Our mission is addressing unmet patient needs through modeling of novel/deep cell binding regions and then designing molecules to fit those regions and effect treatment of that cancer and other diseases. We work with the best researchers – and use the best computational chemistry software – to create effective therapies that only Rasio can make.
Our research and dedicated focus at Rasio Therapeutics is for patients. To help those suffering from cancer and other diseases, we manage novel drug development from discovery to delivery, partnering with appropriate entities as we progress each product.
​© 2020 Rasio All Rights Reserved